Large language models (LLMs) have shown growing potential for Cognitive Behavioral Therapy (CBT) counseling. However, most existing approaches still formulate counseling as a local response generation problem, focusing on empathetic replies within short, text-only, or single-session interactions. We argue that this formulation fundamentally mismatches the nature of real psychotherapy. In clinical CBT, therapy is a longitudinal process in which therapists continuously infer, update, and intervene on evolving therapeutic states across sessions. Realistic CBT further involves multimodal inference and delayed cross-session intervention effects, requiring models to capture longitudinal therapeutic state evolution under partial observability. We propose DMT-CBT, a framework for Dynamic Modeling of evolving Therapeutic states in CBT counseling. DMT-CBT maintains structured therapeutic states across sessions while incorporating multimodal behavioral grounding and tool-augmented intervention to support adaptive therapeutic reasoning. Based on this framework, we construct DMTCorpus, a synthetic multi-session multimodal CBT counseling dataset featuring evolving therapeutic states, image-groun
Metabolism plays a crucial role in sleep regulation, yet its effects are challenging to track in real time. This study introduces a machine learning-based framework to analyze sleep patterns and identify how metabolic changes influence sleep at specific time points. We first established that sleep periods in Drosophila melanogaster function independently, with no causal relationship between different sleep episodes. Using gradient boosting models and explainable artificial intelligence techniques, we quantified the influence of time-dependent sleep features. Causal inference and autocorrelation analyses further confirmed that sleep states at different times are statistically independent, providing a robust foundation for exploring metabolic effects on sleep. Applying this framework to flies with altered monocarboxylate transporter 2 expression, we found that changes in ketone transport modified sleep stability and disrupted transitions between day and night sleep. In an Alzheimers disease model, metabolic interventions such as beta hydroxybutyrate supplementation and intermittent fasting selectively influenced the timing of day to night transitions rather than uniformly altering sl
The origin of life required the emergence of metabolism, an autocatalytic network of enzymatic reactions that synthesize amino acids, nucleotides and cofactors. At the origin of metabolism there were no enzymes--how did it start? Empirical studies addressing early metabolic evolution are lacking. Harnessing protein structures for metabolic enzymes, we identify intermediate states in primordial metabolic assembly. We show that enzymatic metabolism in the universal common ancestor was incomplete, undergoing final assembly independently in the lineages leading to Bacteria and Archaea. Native transition metals--Fe0, Co0, Ni0, Pd0--served as the catalytic forerunners of both enzymes and cofactors at metabolic origin while phosphite supplied energy, as it phosphorylates AMP to ADP and serine to phosphoserine using native metal catalysts in water. Phosphite and native metals occur in serpentinizing hydrothermal systems, identifying an energy-supplying, catalytic site of metabolic origin. Cofactors liberated nascent metabolism from native metal catalysts, engendering its autocatalytic state.
Therapeutic art activities, such as expressive drawing and painting, require the synergy between creative visual production and interactive dialogue. Recent advancements in Multimodal Large Language Models (MLLMs) have expanded the capacity of computing systems to interpret both textual and visual data, offering a new frontier for AI-mediated therapeutic support. This work-in-progress paper introduces an MLLM-powered chatbot that analyzes visual creation in real-time while engaging the creator in reflective conversations. We conducted an evaluation with five experts in art therapy and related fields, which demonstrated the chatbot's potential to facilitate therapeutic engagement, and highlighted several areas for future development, including entryways and risk management, bespoke alignment of user profile and therapeutic style, balancing conversational depth and width, and enriching visual interactivity. These themes provide a design roadmap for designing the future AI-mediated creative expression tools.
Biological systems are governed by coupled interactions between intracellular metabolism and bioreactor operation that span multiple time scales. Constraint-based metabolic models are widely used to describe intracellular metabolism, but repeatedly solving the optimization problem at each time step in dynamic models introduces numerical challenges related to infeasibility and computational efficiency. This work presents a multi-scale modeling framework that integrates genome-scale, constraint-based metabolic models with dynamic bioreactor simulations. Intracellular metabolism is described using positive flux variables in a parsimonious flux balance analysis, and the resulting embedded optimization problem is replaced by a neural network surrogate. The surrogate provides a smooth approximation of the embedded optimization mapping and eliminates repeated linear program solves during simulation. The approach is demonstrated for fed-batch fermentation of Escherichia coli, in which the surrogate model yields intracellular fluxes under substrate-limited conditions, whereas the underlying linear program would otherwise be infeasible. The framework provides a continuous representation of i
Background: Large language models have demonstrated strong performance on general medical examinations, but subspecialty clinical reasoning remains challenging due to rapidly evolving guidelines and nuanced evidence hierarchies. Methods: We evaluated January Mirror, an evidence-grounded clinical reasoning system, against frontier LLMs (GPT-5, GPT-5.2, Gemini-3-Pro) on a 120-question endocrinology board-style examination. Mirror integrates a curated endocrinology and cardiometabolic evidence corpus with a structured reasoning architecture to generate evidence-linked outputs. Mirror operated under a closed-evidence constraint without external retrieval. Comparator LLMs had real-time web access to guidelines and primary literature. Results: Mirror achieved 87.5% accuracy (105/120; 95% CI: 80.4-92.3%), exceeding a human reference of 62.3% and frontier LLMs including GPT-5.2 (74.6%), GPT-5 (74.0%), and Gemini-3-Pro (69.8%). On the 30 most difficult questions (human accuracy less than 50%), Mirror achieved 76.7% accuracy. Top-2 accuracy was 92.5% for Mirror versus 85.25% for GPT-5.2. Conclusions: Mirror provided evidence traceability: 74.2% of outputs cited at least one guideline-tier so
The metabolic network plays a crucial role in regulating bacterial metabolism and growth, but it is subject to inherent molecular stochasticity. Previous studies have utilized flux balance analysis and the maximum entropy method to predict metabolic fluxes and growth rates, while the underlying principles governing bacterial metabolism and growth, especially the criticality hypothesis, remain unclear. In this study, we employ a maximum entropy approach to investigate the universality in various constraint-based metabolic networks of Escherichia coli. Our findings reveal the existence of universal scaling relations across different nutritional environments and metabolic network models, similar to the universality observed in physics. By analyzing single-cell data, we confirm that metabolism of Escherichia coli operates close to the state with maximum Fisher information, which serves as a signature of criticality. This critical state provides functional advantages such as high sensitivity and long-range correlation. Moreover, we demonstrate that a metabolic system operating at criticality takes a compromise solution between growth and adaptation, thereby serving as a survival strateg
Representation of cities as organisms with metabolic processes is a useful analogy for urban design, development and sustainability. Urban metabolism can be modeled by representing urban systems as networks. The various networks included in a city's metabolism are interdependent in complex ways. Thus, understanding the interaction among these networks is essential to understanding how a healthy urban metabolism is sustained and how injuries to the metabolic system can "heal". It is particularly important to understand how disruptions to one system in an urban area affect the functioning of other systems. Using distribution-level data from a real U.S. city on the electricity distribution system and road geometry, we apply connected network modeling to two critical inter-connected urban infrastructure sectors: energy and transportation. We quantify the robustness of these interdependent networks by evaluating the connectivity disruptions that may occur due to natural or synthetic disruptive events, using both unweighted and weighted metrics.
Metabolic disorders, particularly type 2 diabetes mellitus (T2DM), represent a significant global health burden, disproportionately impacting genetically predisposed populations such as the Pima Indians (a Native American tribe from south central Arizona). This study introduces a novel machine learning (ML) framework that integrates predictive modeling with gene-agnostic pathway mapping to identify high-risk individuals and uncover potential therapeutic targets. Using the Pima Indian dataset, logistic regression and t-tests were applied to identify key predictors of T2DM, yielding an overall model accuracy of 78.43%. To bridge predictive analytics with biological relevance, we developed a pathway mapping strategy that links identified predictors to critical signaling networks, including insulin signaling, AMPK, and PPAR pathways. This approach provides mechanistic insights without requiring direct molecular data. Building upon these connections, we propose therapeutic strategies such as dual GLP-1/GIP receptor agonists, AMPK activators, SIRT1 modulators, and phytochemical, further validated through pathway enrichment analyses. Overall, this framework advances precision medicine by
Therapeutic development is a costly and high-risk endeavor that is often plagued by high failure rates. To address this, we introduce TxGemma, a suite of efficient, generalist large language models (LLMs) capable of therapeutic property prediction as well as interactive reasoning and explainability. Unlike task-specific models, TxGemma synthesizes information from diverse sources, enabling broad application across the therapeutic development pipeline. The suite includes 2B, 9B, and 27B parameter models, fine-tuned from Gemma-2 on a comprehensive dataset of small molecules, proteins, nucleic acids, diseases, and cell lines. Across 66 therapeutic development tasks, TxGemma achieved superior or comparable performance to the state-of-the-art generalist model on 64 (superior on 45), and against state-of-the-art specialist models on 50 (superior on 26). Fine-tuning TxGemma models on therapeutic downstream tasks, such as clinical trial adverse event prediction, requires less training data than fine-tuning base LLMs, making TxGemma suitable for data-limited applications. Beyond these predictive capabilities, TxGemma features conversational models that bridge the gap between general LLMs an
Cancer cells exhibit significant alterations in their metabolism, characterised by a reduction in oxidative phosphorylation (OXPHOS) and an increased reliance on glycolysis, even in the presence of oxygen. This metabolic shift, known as the Warburg effect, is pivotal in fuelling cancer's uncontrolled growth, invasion, and therapeutic resistance. While dysregulation of many genes contributes to this metabolic shift, the tumour suppressor gene p53 emerges as a master player. Yet, the molecular mechanisms remain elusive. This study introduces a comprehensive mathematical model, integrating essential p53 targets, offering insights into how p53 orchestrates its targets to redirect cancer metabolism towards an OXPHOS-dominant state. Simulation outcomes align closely with experimental data comparing glucose metabolism in colon cancer cells with wild-type and mutated p53. Additionally, our findings reveal the dynamic capability of elevated p53 activation to fully reverse the Warburg effect, highlighting the significance of its activity levels not just in triggering apoptosis (programmed cell death) post-chemotherapy but also in modifying the metabolic pathways implicated in treatment resis
Genome-scale metabolic models have become a fundamental tool for examining metabolic principles. However, metabolism is not solely characterized by the underlying biochemical reactions and catalyzing enzymes, but also affected by regulatory events. Since the pioneering work of Covert and co-workers as well as Shlomi and co-workers it is debated, how regulation and metabolism synergistically characterize a coherent cellular state. The first approaches started from metabolic models which were extended by the regulation of the encoding genes of the catalyzing enzymes. By now, bioinformatics databases in principle allow addressing the challenge of integrating regulation and metabolism on a system-wide level. Collecting information from several databases we provide a network representation of the integrated gene regulatory and metabolic system for Escherichia coli, including major cellular processes, from metabolic processes via protein modification to a variety of regulatory events. Besides transcriptional regulation, we also take into account regulation of translation, enzyme activities and reactions. Our network model provides novel topological characterizations of system components
Traditional Indian (Ayurvedic) and Chinese herbal medicines have been used in the treatment of a variety of diseases for thousands of years because of their natural origin and lesser side effects. However, the safety and efficacy data (including dose and quality parameters) on most of these traditional medicines are far from sufficient to meet the criteria needed to support their world-wide therapeutic use. Also, the mechanistic understanding of most of these herbal medicines is still lacking due to their complex components which further limits their wider application and acceptance. Metabolomics -a novel approach to reveal altered metabolism (biochemical effects) produced in response to a disease or its therapeutic intervention- has huge potential to assess the pharmacology and toxicology of traditional herbal medicines (THMs). Therefore, it is gradually becoming a mutually complementary technique to genomics, transcriptomics and proteomics for therapeutic evaluation of pharmaceutical products (including THMs); the approach is so called pharmaco-metabolomics. The whole paradigm is based on its ability to provide metabolic signatures to confirm the diseased condition and then to us
Thanks to the increasing availability of genomics and other biomedical data, many machine learning approaches have been proposed for a wide range of therapeutic discovery and development tasks. In this survey, we review the literature on machine learning applications for genomics through the lens of therapeutic development. We investigate the interplay among genomics, compounds, proteins, electronic health records (EHR), cellular images, and clinical texts. We identify twenty-two machine learning in genomics applications across the entire therapeutics pipeline, from discovering novel targets, personalized medicine, developing gene-editing tools all the way to clinical trials and post-market studies. We also pinpoint seven important challenges in this field with opportunities for expansion and impact. This survey overviews recent research at the intersection of machine learning, genomics, and therapeutic development.
A classic problem in metabolism is that fast-proliferating cells use seemingly wasteful fermentation for energy biogenesis in the presence of sufficient oxygen. This counterintuitive phenomenon, known as overflow metabolism or the Warburg effect, is universal across various organisms. Despite extensive research, its origin and function remain unclear. Here, we show that overflow metabolism can be understood through growth optimization combined with cell heterogeneity. A model of optimal protein allocation, coupled with heterogeneity in enzyme catalytic rates among cells, quantitatively explains why and how cells choose between respiration and fermentation under different nutrient conditions. Our model quantitatively illustrates the growth rate dependence of fermentation flux and enzyme allocation under various perturbations and is fully validated by experimental results in Escherichia coli. Our work provides a quantitative explanation for the Crabtree effect in yeast and the Warburg effect in cancer cells and can be broadly used to address heterogeneity-related challenges in metabolism.
We introduce a generalized continuous-time compartment model of ethanol metabolism in the human body that extends a recently developed framework. In the proposed model, we replace the Michaelis-Menten mechanism of the liver's ethanol metabolism rate with a general class of nonlinear rate functions. This modification provides greater modeling flexibility and enables the model to capture a wider range of hepatic ethanol metabolism dynamics. The qualitative behavior of the proposed ethanol metabolism model is analyzed rigorously. More specifically, we investigate the positivity and boundedness of solutions, as well as the global asymptotic stability (GAS) of the unique equilibrium point using an appropriate quadratic Lyapunov function. Second, we formulate a discrete-time counterpart of the proposed continuous-time model and investigate its dynamical properties. We show that, under an appropriate condition on the time step size, the discrete-time model faithfully reproduces the qualitative dynamical behavior of the corresponding continuous-time system. Lastly, we conduct a series of numerical experiments employing several ethanol metabolism rate functions to support the theoretical re
We outline a modeling and optimization strategy for investigating dynamic metabolic engineering interventions. Our framework is particularly useful at the early stages of research and development, often constrained by limited knowledge and experimental data. Elucidating a priori optimal trajectories of manipulatable intracellular fluxes can guide the design of suitable control schemes, e.g., cyber(ge)netic or in-cell approaches, and the selection of appropriate actuators, e.g., at the transcriptional or post-translational levels. Model-based dynamic optimization is proposed to predict optimal trajectories of target manipulatable intracellular fluxes. A challenge emerges as existing models are often oversimplified, lacking insights into metabolism, or excessively complex, making them difficult to build and implement. Here, we use surrogates derived from steady-state solutions of constraint-based metabolic models to link manipulatable intracellular fluxes to the process exchange rates of structurally simple hybrid dynamic models. The latter can be conveniently used in optimal control problems of metabolism. As a proof of concept, we apply our method to a reduced metabolic network of
Living systems continuously transform matter and energy through the chemical processes that constitute their metabolism. The overall metabolic rate of an organism correlates positively with its body mass, however both the exact scaling behavior and possible explanations for this behavior have been under intense debate for two centuries. This review synthesizes empirical findings and theoretical frameworks on the energetics of living systems from an interdisciplinary perspective, with a focus on physical concepts. A general thermodynamic framework to study metabolism is laid out, together with a coarse-grained description of metabolic biochemistry. The rich history of experimental work in this field is surveyed, revealing a variety of metabolic scaling patterns at different levels of biological organization, from individual cells to whole populations. Several biophysical models proposed to explain the sublinear scaling of metabolic rate with body mass are summarized. Though the traditional focus has been on adult organisms, the review also highlights recent advances that probe metabolism during development. Improvements in experimental techniques, extensive datasets, and a host of o
Metabolic models condense biochemical knowledge about organisms in a structured and standardised way. As large-scale network reconstructions are readily available for many organisms, genome-scale models are being widely used among modellers and engineers. However, these large models can be difficult to analyse and visualise and occasionally generate predictions that are hard to interpret or even biologically unrealistic. Of the thousands of enzymatic reactions in a typical bacterial metabolism, only a few hundred form the metabolic pathways essential to produce energy carriers and biosynthetic precursors. These pathways carry relatively high flux, are central to maintaining and reproducing the cell, and provide precursors and energy to engineered metabolic pathways. Focusing on these central metabolic subsystems, we present iCH360, a manually curated medium-scale model of energy and biosynthesis metabolism for the well-studied bacterium Escherichia coli K-12 MG1655. The model is a sub-network of the most recent genome-scale reconstruction, iML1515, and comes with an updated layer of database annotations and with a range of metabolic maps for visualisation. We enriched the stoichiom
Antibody therapies have been employed to address some of today's most challenging diseases, but must meet many criteria during drug development before reaching a patient. Humanization is a sequence optimization strategy that addresses one critical risk called immunogenicity - a patient's immune response to the drug - by making an antibody more "human-like" in the absence of a predictive lab-based test for immunogenicity. However, existing humanization strategies generally yield very few humanized candidates, which may have degraded biophysical properties or decreased drug efficacy. Here, we re-frame humanization as a conditional generative modeling task, where humanizing mutations are sampled from a language model trained on human antibody data. We describe a sampling process that incorporates models of therapeutic attributes, such as antigen binding affinity, to obtain candidate sequences that have both reduced immunogenicity risk and maintained or improved therapeutic properties, allowing this algorithm to be readily embedded into an iterative antibody optimization campaign. We demonstrate in silico and in lab validation that in real therapeutic programs our generative humanizati